hahaha, professional investors are staying away. that's why most of thld stocks are owned by institutions. in special ed tim's world, institutional investors are not considered professional. nope, in timmy's world, the only professionals are clueless news chasing traders and crooked hedge funds. as for us retail, we don't matter, and neither does our countless years of experience investing in biotech. yup, we're not professional b/c we are putting our own money on the line instead of trading with other people's money. hmmm, i wonder who puts more time into DD? retail investing his own money or traders chasing news? keep up the good work special ed tim.
special ed tim, investing is not politics. you can scream a lie until you're red in the face but that will not convince the masses that you are telling the truth. for any season biotech investor, you are as transparent as glass and as fake as a 3 dollar bill.
special ed tim thinks he's the point man on all thing institutions. institution passes gas and timmy boy rushes over to announce the GREAT news. special ed tim, why don't you tell us again about how institutions are staying away from thld? idiot
marketcrooks, the scam is the existence of MM and how they are allowed to naked short. b/c of them, the real demand and supply for a stock is muddied and what we get instead is fake liquidity and constant volatility. there's no reason why MM need to exist since i'm sure the market is big enough to function just fine without them providing their fake liquidity.
special ed tim, why do you constantly rant about merck's poor R&D production. you keep on humming this tune in a sad attempt to cast doubt on th-302 as if thld has anything to do with merck's R&D. If anything, the more problems merck has with R&D, the more valuable th-302 will be for them. that's simple to understand; even for someone as special as you, right?
stock will be over 20 and where it settles, no one will know since investors will have other future indications dancing in their head.
nope, the big boys didn't sell high buy low with my shares. all this vol is good for traders but for me, the only thing that will matter is the data and FDA approval. time is on my side.
i'll put my trust with thld management and the data over any analyst hack any day. selick has mention numerous times that th-302 works equally well across all sub-types of STS and the clinical data to date shows this to be the case. I'll trust that the decision to go into all sub-types by management was based on data and science instead of some whim.
i've learned long ago to not put any trust on analysts or media hacks or bloggers or anyone else out there who's trying to push their opinions. at the end of the day, it's all about your own DD and where it leads you.
beach, say it ain't so. oh no, the institutions are adding to their position -- the sky is falling. who would have thought. according to our resident idiot, opps, i mean institution expert special ed tim, the institutions don't believe in th-302 and are staying away. i would expect institution ownership to continue to increase as we go into the interim readout.
special ed tim, i guess exposing your lies, being excited about the data for th-302, guessing about what's in going on behind the scene, and being enthusiastic about the potential approval of th-302 in multiple indications is what you call pumping? here's a news flash, this is what longs who believe in their investments are suppose to talk about. after all, why buy stock in a company if you don't expect it to be successful, which is especially true for speculative companies.
what you're doing is not called being long idiot; it's called "bashing" a company and spreading FUD (Fear, Uncertainty, and Doubt). people like your are what longs call "shorts" b/c it's usually shorts who follow this line of behavior since no sane person would buy stock in a company they thrash. not saying you're short but i sure hope you are and that you stay that way going into th-302's binary events.
i know it's difficult for someone as special as you to understand so i don't expect any of this to register in to that void you call a head. keep up the good work shorty.
special ed tim, the word has already been let out and the word is that you're an idiot. what did the idiot say again? oh, yeah, special ed tim said institutions don't believe in th-302 and are sitting on the sideline. continue the good work special ed tim.
special ed tim, how does it feel when words out of your mouth is shoved back up your behind? learn to enjoy it, there will be more of this coming your way.
special ed tim is licking his chop hoping for a pop on this news so he can short and make a few pennies since he expects the MM to take it back down after the excitement fades.
keep up the good work special ed tim, only a about 3 more months left to play your churning game for pennies.
special ed tim is playing out like a broken record. boo hoo hoo... there are no funds invested in this company, the market cap is so small, no one places any value on the technology, no one believes the phase III trial will be successful... boo hoo hoo, thld will stay this way forever.
it must have slipped little tim's pea brain that thld is a speculative investment that is waiting on binary events and that it's natural for such investments to be undervalued when the outcome is not certain. it is also in these type of investments where you have to do you own DD to come up with your own valuation instead of blindly assuming market's is correct. but us retail are too stupid to know this, right? keep up the good work special ed tim.
special ed tim, only knows how to fling insults. him mind is void of any meaningful thought. that's why he's so special. keep up the good work special ed tim.
the officers getting the options are also responsible for drug production. wonder what they did to earn them these rewards? could management be preparing for commercializing b/c they are expecting successful interim results?
mclim, special ed tim, is a FUDster i.e. someone who tries to spread Fear, Uncertainty, and Doubt (FUD). he is clueless and his only argument for why thld is a bad investment is that "professional investors" and "biotech experts" are staying away. never mind that baker brothers and other institutions have added to their position. occasionally, he'll also fall back insulting thld management and how they are all failures b/c they failed to get any of their other previous drugs approved. as if the other drugs have anything to do with th-302. so, in summary, don't hold your breath expecting special ed tim to contribute any meaning info to this investment. if you want, do like me and beach, by using special ed tim as a cheap punching bag as we wait for data.
special ed tim, knows he won't have a leg to stand on if he strait out says the STS trial will fail since even a blind fool can see that the phase II STS data for th-302 is exceptional. so, instead, special ed tim is lying about how even if thld is successful in STS, the price will at best only double to 10. he thinks us retail investors are gullible enough to believe his deceit.
yes, special ed tim, an approval in a major cancer will only result in thld's market cap doubling to only 500 mil. yes, gullible retail investor are too stupid to see how almost all biotech in a similar situation in the past has seen their market cap at minimum shoot to multiple billions on approval of their first cancer drug. yes, thld will break from historical trend just b/c you say so. keep up the good work special ed tim.
dull culley, yes i have no investment skills, i've only grown my portfolio by about 24 times since the last decade to date. pure growth without any additional contribution since then. since you're such a player, what was your return over the last decade? fool